Active
Small Business
Overview
- Legal name
- HEALTH DECISIONS, INC.
- Registered location
- MORRISVILLE, NC, USA
- Website
- Company website ↗
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Sep 10, 2026
Read company summary
HEALTH DECISIONS, INC. is associated with UEI CMKQYLSLNJG1 and CAGE 3FAM0 in public federal records. AcornBids currently links 12 prime awards totaling $42.1M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists MORRISVILLE, NC, USA.
At a glance
Lifetime prime obligations$42.1M
Prime awards12
Awards with future end dates6
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 8, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- HEALTH DECISIONS, INC.
- UEI
- CMKQYLSLNJG1
- CAGE
- 3FAM0
- Registered address
- 3800 PARAMOUNT PKWY, MORRISVILLE, NC, 27560, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Feb 18, 2026
- Initial registration
- May 6, 2003
- Entity start
- Mar 29, 2018
- SAM updated
- Feb 18, 2026
- Registration expires
- Feb 16, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Research brief
Source facts
- Loaded prime-award records link 12 awards and $42,091,266 in reported obligations to this legal entity. Source
- Recorded awards include Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (NAICS 541715); this classification is not proof of every company capability. Source
- An example award describes: TASK ORDER 2: STATUS DETERMINATION AND PRIORITIZATION OF PIPELINE PRODUCTS UNDERGOING CLINICAL TRIALS FOR MALE AND FEMALE CONTRACEPTION Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Selected transaction obligations$19.2M
Prime contracts
$669.8KFY2013$0FY2016$291.9KFY2018$1.8MFY2019$753.0KFY2020$743.1KFY2021$1.3MFY2022$2.9MFY2023$4.9MFY2024$3.1MFY2025$2.8MFY2026
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 12 of 12 selected awards. Select a period to explore its awards.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N94019F00126TASK ORDER 2: STATUS DETERMINATION AND PRIORITIZATION OF PIPELINE PRODUCTS UNDERGOING CLINICAL TRIALS FOR MALE AND FEMALE CONTRACEPTION | Department of Health and Human Services | $2.5M | Sep 24, 2019 | Dec 31, 2028 |
| 75N94025F00002NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLE | Department of Health and Human Services | $1.3M | Aug 1, 2025 | Mar 31, 2028 |
| 75N94023F00003FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL | Department of Health and Human Services | $2.2M | Sep 1, 2023 | Jul 31, 2027 |
| 75N94025F00001NICHD: R&D: COORDINATION, MONITORING, FOLLOW-UP, EVALUATION, AND COMPLETION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE | Department of Health and Human Services | $1.2M | May 1, 2025 | Oct 31, 2027 |
| 75N94023F00002STATISTICAL AND CLINICAL COORDINATING SERVICES FOR GROUPS C AND D OF CCN021 ENTITLED, "A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB)… | Department of Health and Human Services | $2.3M | May 25, 2023 | Oct 21, 2026 |
| HHSN27500005IGF::OT::IGF EVALUATION OF THE PHARMACOKINETIC PROFILE, EFFECTS ON THE MECHANISMS OF CONTRACEPTIVE EFFICACY AND SAFETY OF MULTIPURPOSE PREVENTION TECHNOLOGIES PRODUCTS | Department of Health and Human Services | $3.2M | Sep 24, 2013 | Dec 31, 2025 |
| 75N94019F00125TO AWARD TASK ORDER 75N94019F0025, INTERNAL NO. TASK ORDER 1 TITLE CORE FUNCTION ACTIVITIES FOR THE "NICHD CCTN STATISTICAL AND CLINICAL COORDINATING CENTER" SEPTEMBER 20, 2019… | Department of Health and Human Services | $3.6M | Sep 20, 2019 | Sep 19, 2026 |
| 75N94024F00002ACQUISITION OF THE NESTORONE ESTRADIOL (NES/E2) VAGINAL RING | Department of Health and Human Services | $1.2M | Sep 25, 2024 | Sep 25, 2026 |
| 75N94023F00001COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION | Department of Health and Human Services | $6.4M | Jan 1, 2023 | Apr 30, 2025 |
| HHSN27500006IGF::OT::IGF CONTRACEPTIVE CLINICAL TRIALS NETWORK TO6 - COORDINATION OF CLINICAL TRIALS OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION - | Department of Health and Human Services | $7.4M | Apr 13, 2016 | Apr 30, 2025 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Feb 18, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | May 6, 2003 |
| Entity start | Mar 29, 2018 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| DEVONE PUNTER | Government business | Contact method not published | SAM registration | Not available |
| CLINT DART | Alternate government business | Contact method not published | SAM registration | Not available |
| CLINT DART | Electronic business | Contact method not published | SAM registration | Not available |
| DEVONE PUNTER | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
4 awards
5 awards
16 awards
About HEALTH DECISIONS, INC.
What products and services appear in its federal awards?
Recorded award industries: 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology); 541712.
Recorded products and services: AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH.
Examples from recent award records:
- TASK ORDER 2: STATUS DETERMINATION AND PRIORITIZATION OF PIPELINE PRODUCTS UNDERGOING CLINICAL TRIALS FOR MALE AND FEMALE CONTRACEPTION
- NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLE
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
3800 PARAMOUNT PKWY, MORRISVILLE, North Carolina 27560, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit